Published in Cell Transplant on October 18, 2013
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med (2000) 18.26
International trial of the Edmonton protocol for islet transplantation. N Engl J Med (2006) 13.43
Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev (2011) 4.15
Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika (1951) 3.29
Clinical islet transplantation: advances and immunological challenges. Nat Rev Immunol (2004) 2.40
Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet (2005) 2.39
Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes (1996) 2.04
A simple method of staining fresh and cultured islets. Transplantation (1988) 2.03
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Islet transplantation: a brave new world. Diabetes (2003) 1.84
Glucose-induced insulin release depends on functional cooperation between islet cells. Proc Natl Acad Sci U S A (1982) 1.79
Superiority of small islets in human islet transplantation. Diabetes (2007) 1.76
Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. Am J Transplant (2008) 1.68
Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS One (2008) 1.67
Small rat islets are superior to large islets in in vitro function and in transplantation outcomes. Am J Physiol Endocrinol Metab (2005) 1.66
The role of total pancreatectomy and islet autotransplantation for chronic pancreatitis. Surg Clin North Am (2007) 1.63
A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. Transplantation (1995) 1.53
Quantitative analysis of cell composition and purity of human pancreatic islet preparations. Lab Invest (2010) 1.43
A new enzyme mixture to increase the yield and transplant rate of autologous and allogeneic human islet products. Transplantation (2012) 1.30
Functional differences between rat islets of ventral and dorsal pancreatic origin. J Clin Invest (1982) 1.27
Toward maximizing the success rates of human islet isolation: influence of donor and isolation factors. Cell Transplant (2007) 1.26
Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts. J Exp Med (1990) 1.23
Revascularization and microcirculation of freely grafted islets of Langerhans. World J Surg (2001) 1.19
Evaluation of islet transplantation from non-heart beating donors. Am J Transplant (2006) 1.18
Prediction of clinical outcome in islet allotransplantation. Diabetes Care (2007) 1.08
Autoimmunity after islet-cell allotransplantation. N Engl J Med (2006) 1.08
Angiogenesis and vascularization of murine pancreatic islet isografts. Transplantation (1995) 1.07
Pancreas islets in metabolic signaling--focus on the beta-cell. Front Biosci (2008) 1.06
Islet transplantation in patients with diabetes mellitus: choice of immunosuppression. BioDrugs (2004) 1.01
A local glucose-and oxygen concentration-based insulin secretion model for pancreatic islets. Theor Biol Med Model (2011) 1.00
Structure-function relationships in pancreatic islets: support for intraislet modulation of insulin secretion. Endocrinology (1985) 1.00
Minimization and withdrawal of steroids in pancreas and islet transplantation. Transpl Int (2008) 0.99
Long-term in vivo function of human mantled islets obtained by incomplete pancreatic dissociation and purification. Transplant Proc (1995) 0.97
Effects of oxygen on metabolic and secretory activities of beta TC3 cells. Biochim Biophys Acta (1996) 0.96
Markedly decreased blood perfusion of pancreatic islets transplanted intraportally into the liver: disruption of islet integrity necessary for islet revascularization. Diabetes (2012) 0.95
A microfluorometric viability assay for isolated human and rat islets of Langerhans. Diabetes Res (1989) 0.95
Size-based separation and collection of mouse pancreatic islets for functional analysis. Biomed Microdevices (2010) 0.94
Immunocytochemical and ultrastructural heterogeneities of normal and glibenclamide stimulated pancreatic beta cells in the rat. Virchows Arch (1994) 0.89
Revascularization and remodelling of pancreatic islets grafted under the kidney capsule. J Anat (2007) 0.89
Risks and benefits of transplantation in the cure of type 1 diabetes: whole pancreas versus islet transplantation. A single center study. Rev Diabet Stud (2011) 0.89
Morphological changes of isolated rat pancreatic islets: a structural, ultrastructural and morphometric study. J Anat (2006) 0.88
Quality control for clinical islet transplantation: organ procurement and preservation, the islet processing facility, isolation, and potency tests. J Hepatobiliary Pancreat Surg (2009) 0.88
Pancreas preservation for pancreas and islet transplantation. Curr Opin Organ Transplant (2008) 0.87
Nonrandom distribution of gap junctions between pancreatic beta-cells. Am J Physiol (1980) 0.87
Establishment of fluorescein diacetate and ethidium bromide (FDAEB) assay for quality assessment of isolated islets. Cell Transplant (2000) 0.87
Pancreatic islet transplantation. World J Gastrointest Surg (2009) 0.86
Small islets are essential for successful intraportal transplantation in a diabetes mouse model. Scand J Immunol (2010) 0.85
Early assessment of apoptosis in isolated islets of Langerhans. Transplantation (2001) 0.84
Beneficial effects of ischemic preconditioning on pancreas cold preservation. Cell Transplant (2012) 0.83
Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network. Transplantation (2011) 0.83
The effects of digestion enzymes on islet viability and cellular composition. Cell Transplant (2012) 0.82
Morphometry and function of islet cells after different forms of drainage at pancreatic transplantation in rats. Eur Surg Res (1990) 0.79
Cyclosporine toxicity in immunosuppressed streptozotocin-diabetic nonhuman primates. Toxicology (2005) 0.79
Transplanted functional islet mass: donor, islet preparation, and recipient factors influence early graft function in islet-after-kidney patients. Transplantation (2012) 0.77
Extreme subcutaneous, intramuscular and inhaled insulin resistance treated by pancreas transplantation alone. Am J Transplant (2009) 0.76
Survival following primary androgen deprivation therapy among men with localized prostate cancer. JAMA (2008) 5.66
Outcomes of localized prostate cancer following conservative management. JAMA (2009) 5.57
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study. Lancet Oncol (2012) 3.88
Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/ml. Arch Intern Med (2010) 3.85
Tumorigenic effect of some commonly used moisturizing creams when applied topically to UVB-pretreated high-risk mice. J Invest Dermatol (2008) 3.44
Visualizing hepatitis C virus infections in human liver by two-photon microscopy. Gastroenterology (2009) 3.07
Late gastrointestinal toxicities following radiation therapy for prostate cancer. Eur Urol (2011) 2.69
Impact of comorbidity on survival among men with localized prostate cancer. J Clin Oncol (2011) 2.53
Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene. Hepatology (2008) 2.12
Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications. BJU Int (2013) 2.10
A mixture model for estimating the local false discovery rate in DNA microarray analysis. Bioinformatics (2004) 2.03
Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens (2006) 1.95
Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nat Immunol (2003) 1.88
Analyzing excessive no changes in clinical trials with clustered data. Biometrics (2004) 1.87
Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis. Radiother Oncol (2011) 1.75
The role of the death-domain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases. EMBO Rep (2003) 1.73
Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res (2005) 1.72
Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells. Int J Cancer (2008) 1.63
Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol Sin (2008) 1.60
Heart rate variability biofeedback increases baroreflex gain and peak expiratory flow. Psychosom Med (2003) 1.55
Does primary androgen-deprivation therapy delay the receipt of secondary cancer therapy for localized prostate cancer? Eur Urol (2012) 1.55
Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials. Am J Gastroenterol (2006) 1.54
The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation. Genes Dev (2003) 1.54
Predictors of weight gain and cardiovascular risk in a cohort of racially diverse kidney transplant recipients. Nutrition (2002) 1.51
Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage. Cancer Biol Ther (2010) 1.50
A non-parametric method for the comparison of partial areas under ROC curves and its application to large health care data sets. Stat Med (2002) 1.49
MUC1 in macrophage: contributions to cigarette smoke-induced lung cancer. Cancer Res (2013) 1.48
Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda. Clin Gastroenterol Hepatol (2012) 1.47
A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci U S A (2004) 1.47
Essential roles of receptor-interacting protein and TRAF2 in oxidative stress-induced cell death. Mol Cell Biol (2004) 1.43
Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer. Cancer Res (2008) 1.42
Dating violence and substance use among ethnically diverse adolescents. J Interpers Violence (2010) 1.40
Physician staffing in emergency departments: results of a Texas survey. Tex Med (2006) 1.39
Successful long-term repair of hepatic artery pseudoaneurysm following liver transplantation with primary stent-grafting. Liver Transpl (2007) 1.38
17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway. Cancer Res (2006) 1.36
Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis. Cancer J (2003) 1.35
Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells. Carcinogenesis (2007) 1.33
Variation in false-positive rates of mammography reading among 1067 radiologists: a population-based assessment. Breast Cancer Res Treat (2006) 1.30
Asthma diagnosis vs. analysis of anti-asthmatic prescriptions to identify asthma in children. Eur J Clin Pharmacol (2011) 1.26
A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-kappaB pathway and sensitization of apoptosis in lung cancer cells. Mol Pharmacol (2007) 1.23
Caffeine and caffeine sodium benzoate have a sunscreen effect, enhance UVB-induced apoptosis, and inhibit UVB-induced skin carcinogenesis in SKH-1 mice. Carcinogenesis (2006) 1.22
Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells. Mol Cancer Ther (2008) 1.22
A genotyping system capable of simultaneously analyzing >1000 single nucleotide polymorphisms in a haploid genome. Genome Res (2005) 1.21
Strong correlation between meiotic crossovers and haplotype structure in a 2.5-Mb region on the long arm of chromosome 21. Genome Res (2005) 1.20
NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target. Front Biosci (Landmark Ed) (2011) 1.19
Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray. Clin Cancer Res (2003) 1.19
Acquired activation of the Akt/cyclooxygenase-2/Mcl-1 pathway renders lung cancer cells resistant to apoptosis. Mol Pharmacol (2009) 1.18
Multistage genome-wide association meta-analyses identified two new loci for bone mineral density. Hum Mol Genet (2013) 1.17
Differential temporal expression of matrix metalloproteinases after spinal cord injury: relationship to revascularization and wound healing. J Neurosurg (2003) 1.17
Rapid detection and curation of conserved DNA via enhanced-BLAT and EvoPrinterHD analysis. BMC Genomics (2008) 1.14
Stimulatory effect of topical application of caffeine on UVB-induced apoptosis in mouse skin. Oncol Res (2002) 1.14
Analysis of pilot and early phase studies with small sample sizes. Stat Med (2004) 1.13
Tumour necrosis factor receptor 1 mediates endoplasmic reticulum stress-induced activation of the MAP kinase JNK. EMBO Rep (2006) 1.13
Reactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells. J Exp Clin Cancer Res (2010) 1.13
Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis. Clin Cancer Res (2004) 1.13
Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice. Clin Cancer Res (2007) 1.11
EUS elastography for the differentiation of benign and malignant lymph nodes: a meta-analysis. Gastrointest Endosc (2011) 1.10
TNFα induced noncanonical NF-κB activation is attenuated by RIP1 through stabilization of TRAF2. J Cell Sci (2011) 1.09
Immunohistochemical study of thyroid transcription factor-1 and HER2/neu in non-small cell lung cancer: strong thyroid transcription factor-1 expression predicts better survival. Appl Immunohistochem Mol Morphol (2002) 1.08
Sensitization of TNF-induced cytotoxicity in lung cancer cells by concurrent suppression of the NF-kappaB and Akt pathways. Biochem Biophys Res Commun (2007) 1.08
Glucose up-regulates HIF-1 alpha expression in primary cortical neurons in response to hypoxia through maintaining cellular redox status. J Neurochem (2008) 1.08
Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis. J Neuroimmune Pharmacol (2012) 1.08
Radiation-stimulated epigenetic reprogramming of adaptive-response genes in the lung: an evolutionary gift for mounting adaptive protection against lung cancer. Dose Response (2009) 1.07
δ-tocopherol is more active than α - or γ -tocopherol in inhibiting lung tumorigenesis in vivo. Cancer Prev Res (Phila) (2011) 1.07
Cardiac glycosides inhibit TNF-alpha/NF-kappaB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor. Proc Natl Acad Sci U S A (2005) 1.06
Inhibitory effects of voluntary running wheel exercise on UVB-induced skin carcinogenesis in SKH-1 mice. Carcinogenesis (2006) 1.06
Overexpression of survivin is correlated with increased invasion and metastasis of colorectal cancer. J Surg Oncol (2011) 1.06
Anti-asthma medication prescribing to children in the Lombardy Region of Italy: chronic versus new users. BMC Pulm Med (2011) 1.04
Attenuation of TNFSF10/TRAIL-induced apoptosis by an autophagic survival pathway involving TRAF2- and RIPK1/RIP1-mediated MAPK8/JNK activation. Autophagy (2012) 1.04
FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer. Acta Histochem (2012) 1.04
Prevalence and genotype distribution of human papillomavirus in women with cervical cancer or high-grade precancerous lesions in Chengdu, western China. Int J Gynaecol Obstet (2010) 1.02
Gene silencing in the endocrine pancreas mediated by short-interfering RNA. Pancreas (2005) 1.02
Interaction with general transcription factor IIF (TFIIF) is required for the suppression of activated transcription by RPB5-mediating protein (RMP). Cell Res (2003) 1.01
Gene expression of TPA induced differentiation in HL-60 cells by DNA microarray analysis. Nucleic Acids Res (2002) 1.01
Synergistic inhibition of lung tumorigenesis by a combination of green tea polyphenols and atorvastatin. Clin Cancer Res (2008) 1.00
Air pollution and autonomic and vascular dysfunction in patients with cardiovascular disease: interactions of systemic inflammation, overweight, and gender. Am J Epidemiol (2012) 1.00
Associations of lifestyle and physiologic factors with prostate-specific antigen concentrations: evidence from the National Health and Nutrition Examination Survey (2001-2004). Cancer Epidemiol Biomarkers Prev (2008) 1.00
IKKbeta-mediated nuclear factor-kappaB activation attenuates smac mimetic-induced apoptosis in cancer cells. Mol Cancer Ther (2009) 1.00
Genetic factors, viral infection, other factors and liver cancer: an update on current progress. Asian Pac J Cancer Prev (2013) 1.00
Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice. Clin Cancer Res (2006) 1.00
Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice. Hepatology (2011) 0.99
Pap smear use in a population of older Mexican-American women. Women Health (2002) 0.99
Blockage of NF-kappaB by IKKbeta- or RelA-siRNA rather than the NF-kappaB super-suppressor IkappaBalpha mutant potentiates adriamycin-induced cytotoxicity in lung cancer cells. J Cell Biochem (2008) 0.98
Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence. Cancer Prev Res (Phila) (2010) 0.98
δ- and γ-tocopherols, but not α-tocopherol, inhibit colon carcinogenesis in azoxymethane-treated F344 rats. Cancer Prev Res (Phila) (2012) 0.98
Inhibition of extracellular signal-regulated kinase 1 by adenovirus mediated small interfering RNA attenuates hepatic fibrosis in rats. Hepatology (2009) 0.98
Genome-wide association study of copy number variation identified gremlin1 as a candidate gene for lean body mass. J Hum Genet (2011) 0.97
Concordance with World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) guidelines for cancer prevention and obesity-related cancer risk in the Framingham Offspring cohort (1991-2008). Cancer Causes Control (2015) 0.97
Diagnostic utility of cell cycle and apoptosis regulatory proteins in verrucous squamous carcinoma. Appl Immunohistochem Mol Morphol (2005) 0.97
Inhibitory effect of 12-O-tetradecanoylphorbol-13-acetate alone or in combination with all-trans-retinoic acid on the growth of LNCaP prostate tumors in immunodeficient mice. Cancer Res (2004) 0.96
Geographic variations in breast cancer survival among older women: implications for quality of breast cancer care. J Gerontol A Biol Sci Med Sci (2002) 0.96
Hemin induces heme oxygenase-1 in spinal cord vasculature and attenuates barrier disruption and neutrophil infiltration in the injured murine spinal cord. J Neurotrauma (2004) 0.95
Bacterial translocation and intestinal morphological findings in jaundiced rats. Dig Dis Sci (2002) 0.95
Application of expression genomics for predicting treatment response in cancer. Ann N Y Acad Sci (2005) 0.95
Changing trends in human immunodeficiency virus and acquired immunodeficiency syndrome in the population aged 50 and older. J Am Geriatr Soc (2007) 0.95
Adenovirus-mediated transfer of siRNA against PAI-1 mRNA ameliorates hepatic fibrosis in rats. J Hepatol (2009) 0.95